RNA Therapeutics R&D Solution
Benchling’s RNA Therapeutics Solution was developed in partnership with leading industry innovators. For the first time, R&D teams can design chemically modified oligonucleotides, centralize experimental results, standardize on syntax, and collaborate with teammates more effectively on a single platform. This modern digital R&D solution combines the capabilities expected from in silico design tools, ELN, and LIMS into one modern, unified, fully-configurable, and easy-to-use solution that adapts to the rapidly evolving needs of RNA therapeutics R&D.
ACCELERATE YOUR R&D
Simplify collaboration across multidisciplinary teams
Scientists design oligos with intuitive design tools, centralize experimental data, standardize sequence design, and establish a scalable common language across organizations.
Improve data quality and real-time scientific insights
Scientists keep consistent records across experiments, automatically centralize all key results, and aggregate results from diverse assays for real-time visualization in-platform.
Accelerate the speed of the entire RNA therapeutic lifecycle
Scientists and executives quickly track oligo modifications and consequent impact on biological activity to rapidly iterate on oligo candidates with customizable decision support tools.